Evidence map›Paper›PMID 38139150›Full record

ReviewInternational journal of molecular sciences2023

The PPP1R15 Family of eIF2-alpha Phosphatase Targeting Subunits (GADD34 and CReP).

Danielle Hicks, Krithika Giresh, Lisa A Wrischnik, Douglas C Weiser

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Cell surface GRP78 and the UPR pathway as novel promising therapeutic targets in cancer: an insight into the treatment of acute leukemia by using GRP78-CART cells.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Circadian Control of Protein Synthesis.BioEssays : news and reviews in molecular, cellular and developmental biology · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. ISR Modulators in Neurological Diseases.Current neuropharmacology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Danielle HicksDepartment of Science, Mathematics and Engineering, Modesto Junior College, Modesto, CA 95350, USA.ORCID 0009-0002-9927-3238
Krithika GireshDepartment of Biological Sciences, University of the Pacific, Stockton, CA 95211, USA.
Lisa A WrischnikDepartment of Biological Sciences, University of the Pacific, Stockton, CA 95211, USA.
Douglas C WeiserDepartment of Biological Sciences, University of the Pacific, Stockton, CA 95211, USA.
University of the Pacific · US

Funding

Regulation of the Unfolded Protein Response by eIF2 alpha phosphatasesR15GM124601 · NIGMS · UNIVERSITY OF THE PACIFIC-STOCKTON · PI WEISER, DOUGLAS CONRAD · 2017 to 2017
$305k
NIGMS NIH HHS R15 GM124601NIH HHS R15-GM124601
6 · The paper itself

Abstract

The vertebrate PPP1R15 family consists of the proteins GADD34 (growth arrest and DNA damage-inducible protein 34, the product of the PPP1R15A gene) and CReP (constitutive repressor of eIF2α phosphorylation, the product of the PPP1R15B gene), both of which function as targeting/regulatory subunits for protein phosphatase 1 (PP1) by regulating subcellular localization, modulating substrate specificity and assembling complexes with target proteins. The primary cellular function of these proteins is to facilitate the dephosphorylation of eukaryotic initiation factor 2-alpha (eIF2α) by PP1 during cell stress. In this review, we will provide a comprehensive overview of the cellular function, biochemistry and pharmacology of GADD34 and CReP, starting with a brief introduction of eIF2α phosphorylation via the integrated protein response (ISR). We discuss the roles GADD34 and CReP play as feedback inhibitors of the unfolded protein response (UPR) and highlight the critical function they serve as inhibitors of the PERK-dependent branch, which is particularly important since it can mediate cell survival or cell death, depending on how long the stressful stimuli lasts, and GADD34 and CReP play key roles in fine-tuning this cellular decision. We briefly discuss the roles of GADD34 and CReP homologs in model systems and then focus on what we have learned about their function from knockout mice and human patients, followed by a brief review of several diseases in which GADD34 and CReP have been implicated, including cancer, diabetes and especially neurodegenerative disease. Because of the potential importance of GADD34 and CReP in aspects of human health and disease, we will discuss several pharmacological inhibitors of GADD34 and/or CReP that show promise as treatments and the controversies as to their mechanism of action. This review will finish with a discussion of the biochemical properties of GADD34 and CReP, their regulation and the additional interacting partners that may provide insight into the roles these proteins may play in other cellular pathways. We will conclude with a brief outline of critical areas for future study.

Indexed as

Neurodegenerative DiseasesProtein Phosphatase 1AnimalsEukaryotic Initiation Factor-2HumansMiceMice, KnockoutPhosphorylationProtein BiosynthesisProteinsEukaryotic Initiation Factor-2PPP1R15A protein, humanProtein Phosphatase 1ProteinsCRePeIF2αGADD34integrated stress response (ISR)PP1PPP1CAPPP1R15PPP1R15APPP1R15Bunfolded protein response (UPR)

Identifiers

PMID38139150
PMCPMC10743859
OpenAlexW4389566815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.